UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
iShares S&P 500 Value ETF
IVE
$49.8B
| $365K | ﹤0.01% |
3,064
-186
| -6% | -$21.8K |
|
2352
Zoom
ZM
$30.6B
| $364K | ﹤0.01% |
4,773
+948
| +25% | +$85.4K |
|
2353
Citizens
CIA
$192M
| $364K | ﹤0.01% |
52,935
+3,333
| +7% | +$23.3K |
|
|
IMGN
2354
DELISTED
Immunogen Inc
IMGN
| $362K | ﹤0.01% |
149,760
+17,540
| +13% | +$46.6K |
|
|
UCFC
2355
DELISTED
United Community Financial Corp
UCFC
| $362K | ﹤0.01% |
33,600
+15,091
| +82% | +$149K |
|
|
CBAY
2356
DELISTED
Cymabay Therapeutics
CBAY
| $362K | ﹤0.01% |
70,624
+4,096
| +6% | +$24.8K |
|
2357
Liberty Energy
LBRT
$3.25B
| $361K | ﹤0.01% |
33,365
+8,065
| +32% | +$98.9K |
|
2358
Vanguard Extended Market ETF
VXF
$31.7B
| $361K | ﹤0.01% |
3,106
| – | – |
|
2359
Camping World
CWH
$653M
| $360K | ﹤0.01% |
40,423
+24,123
| +148% | +$233K |
|
2360
Kura Oncology
KURA
$850M
| $359K | ﹤0.01% |
+23,672
| New | +$421K |
|
2361
Tencent Music
TME
$15.6B
| $356K | ﹤0.01% |
27,860
-11,055
| -28% | -$156K |
|
|
PLYA
2362
DELISTED
Playa Hotels & Resorts
PLYA
| $355K | ﹤0.01% |
45,310
+17,711
| +64% | +$136K |
|
2363
Travere Therapeutics
TVTX
$5.78B
| $351K | ﹤0.01% |
30,319
+15,721
| +108% | +$260K |
|
|
ATRS
2364
DELISTED
Antares Pharma, Inc.
ATRS
| $350K | ﹤0.01% |
104,765
+54,681
| +109% | +$180K |
|
2365
AB InBev
BUD
$165B
| $349K | ﹤0.01% |
3,664
-50
| -1% | -$4.75K |
|
2366
Mitek Systems
MITK
$835M
| $347K | ﹤0.01% |
36,004
+11,804
| +49% | +$118K |
|
2367
El Pollo Loco
LOCO
$462M
| $347K | ﹤0.01% |
31,671
+5,670
| +22% | +$60K |
|
|
MNK
2368
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $343K | ﹤0.01% |
142,486
+15,133
| +12% | +$77.3K |
|
|
TAST
2369
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $343K | ﹤0.01% |
41,421
+3,017
| +8% | +$25.2K |
|
|
GNMK
2370
DELISTED
GenMark Diagnostics, Inc
GNMK
| $342K | ﹤0.01% |
56,414
+4,468
| +9% | +$27.9K |
|
|
JCP
2371
DELISTED
J.C. Penney Company, Inc.
JCP
| $342K | ﹤0.01% |
384,493
-330,973
| -46% | -$278K |
|
2372
Ubiquiti
UI
$34.3B
| $340K | ﹤0.01% |
2,876
-1,637
| -36% | -$198K |
|
2373
Mistras Group
MG
$512M
| $340K | ﹤0.01% |
+20,712
| New | +$318K |
|
|
CRCM
2374
DELISTED
CARE.COM, INC.
CRCM
| $338K | ﹤0.01% |
32,385
+15,985
| +97% | +$165K |
|
2375
Weis Markets
WMK
$1.86B
| $338K | ﹤0.01% |
8,868
+797
| +10% | +$30.3K |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.